Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis

NCT00276341 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: EGb 761® (Tanakan®)

Sponsor

Ipsen